- Chronic myeloid leukaemia - standardization of BCR-ABL1 transcript level monitoring in the Czech Republic2016 | Publication without faculty affiliation
- Treatment decisions in chronic myeloid leukemia in the view of BCR-ABL1 mutations in practice2010 | Faculty of Medicine in Hradec Králové
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.2018 | First Faculty of Medicine, Central Library of Charles University
- Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology2017 | Second Faculty of Medicine
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia2018 | First Faculty of Medicine, Central Library of Charles University
- Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing2015 | Second Faculty of Medicine, First Faculty of Medicine
- Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells2021 | First Faculty of Medicine
- Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission2020 | Second Faculty of Medicine, First Faculty of Medicine
- Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols2020 | Second Faculty of Medicine
- Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase2015 | First Faculty of Medicine
- Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL12019 | Second Faculty of Medicine
- Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study2021 | Second Faculty of Medicine
- Interferon-alpha Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients2016 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Science
- Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia2017 | Faculty of Science
- Treatment of chronic myeloid leukemia in adults in 20102010 | Faculty of Medicine in Hradec Králové
- Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy2022 | Second Faculty of Medicine
- Termination of the treatment in chronic myeloid leukemia - possi bility of stopping the tyrosine kinase inhibitors2017 | First Faculty of Medicine
- Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients2014 | Faculty of Medicine in Pilsen
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Characterization of leukemias with ETV6-ABL1 fusion2016 | Second Faculty of Medicine
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions2022 | Second Faculty of Medicine
- Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia2015 | Second Faculty of Medicine
- Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib2017 | Publication without faculty affiliation
- Exosomes released by imatinib-resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib-sensitive cells in the presence of imatinib2021 | First Faculty of Medicine, Faculty of Science, Central Library of Charles University
- Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?2017 | Second Faculty of Medicine
- Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group2010 | Second Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases2010 | Second Faculty of Medicine
- Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Science
- Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine